PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
21-Feb-2023 Celanese Completes EVA Capacity Expansion at Acetyl Chain Facility in Edmonton Businesswire
20-Feb-2023 Broad Institute Launches New Website With WDB Agency to Help Researchers Innovate and Forge New Frontiers in Science Newswire
20-Feb-2023 FeedKind® Protein Wins FDA GRAS Status for Use in Aquaculture Businesswire
20-Feb-2023 3D Cell Culture Technologies Global Market Report 2023: Increasing Requirement for Organ Transplantation Drives Sector - ResearchAndMarkets.com Businesswire
20-Feb-2023 Global Quantified Self in Healthcare Market Report 2023 to 2028: Featuring GE Healthcare, Google, Healthcare CRO Company, Honeywell Life Care Solutions and IBM Among Others - ResearchAndMarkets.com Businesswire
20-Feb-2023 The RWS Foundation Launches With a Renewed Purpose and Focus on Unlocking Global Understanding Businesswire
20-Feb-2023 The Second Season of Sailing into the Future. Together Is About to Start Businesswire
20-Feb-2023 Phastar Take Lead on Making Sense of Visual Data Analytics at ACDM23 Barcelona Phastar
20-Feb-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
20-Feb-2023 Sensorion Announces Its Financial Calendar for the First Half of 2023 Businesswire
20-Feb-2023 Almirall’s Full-Year 2022 Results Businesswire
19-Feb-2023 Takeda Presents Positive Results from Phase 3 Study of Vedolizumab for Prevention of Intestinal Acute Graft-Versus-Host Disease (aGvHD) in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) Businesswire
18-Feb-2023 Ligand’s Partner Travere Therapeutics Announces FDA Accelerated Approval of FILSPARI™ (sparsentan), the First and Only Non-immunosuppressive Therapy for the Reduction of Proteinuria in IgA Nephropathy Businesswire
18-Feb-2023 Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, a New Once-Daily Formulation of AUSTEDO® (deutetrabenazine) Tablets Businesswire
17-Feb-2023 Napoli Shkolnik Files Complaint Against Manufacturers of Artificial Tear Products Linked to Bacterial Infections Businesswire
17-Feb-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Kornit Digital Ltd. (KRNT) on Behalf of Investors Businesswire
17-Feb-2023 Genomic Vision announces the issuance of the 2nd tranche of convertible notes with warrants (OCABSA) for €2 million, as part of the financing line concluded with Winance for a maximum amount of €30 million Businesswire
17-Feb-2023 Adjuvant Opdivo (nivolumab) Continues to Provide Significant, Durable Clinical Benefits for Patients with Radically Resected, High-Risk Muscle-Invasive Urothelial Carcinoma After Three Years in CheckMate -274 Trial Businesswire
17-Feb-2023 Bio-Rad to Participate in Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Conference Businesswire
17-Feb-2023 Equillium Announces Oral Presentation at the Tandem Meetings of ASTCT and CIBMTR Businesswire